Truth Social post of June 25, 2026
PostStatementPublished 06/25Open the original
Summary
President Trump announces the nomination of Chris Klomp as Deputy Secretary of HHS, saying he has led Medicare operations and will drive reforms including the Most Favored Nation drug pricing policy.
By industry
- Healthcare & Drug Pricing1 trading day+1.6%p15 stocks5 trading days+2.0%p15 stocks20 trading days+5.1%p15 stocks
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 26/06/24 | 0.0% | 0.0% |
| 26/06/25 | +1.1% | −0.4% |
| 26/06/26 | +3.4% | −0.9% |
| 26/06/29 | +3.2% | +0.5% |
| 26/06/30 | +2.5% | +1.2% |
| 26/07/01 | +3.1% | +1.1% |
| 26/07/02 | +5.5% | +0.9% |
| 26/07/06 | +3.9% | +1.9% |
| 26/07/07 | +6.0% | +1.4% |
| 26/07/08 | +5.7% | +1.0% |
| 26/07/09 | +5.0% | +1.9% |
| 26/07/10 | +4.4% | +2.5% |
| 26/07/13 | +5.5% | +1.5% |
| 26/07/14 | +4.1% | +2.0% |
| 26/07/15 | +3.3% | +2.4% |
| 26/07/16 | +5.0% | +1.7% |
| 26/07/17 | +5.0% | +0.7% |
| 26/07/20 | +4.1% | +0.6% |
| 26/07/21 | +5.3% | +1.4% |
| 26/07/22 | +4.5% | +1.2% |
| 26/07/23 | +5.3% | +0.2% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Dermot Mark Durcan
BuyCencora
BuyCencora
COR
$1.1M
4,000 sh
$1.1M
Filed 06/22
Traded 06/18
- Dermot Mark Durcan
BuyCencora
BuyCencora
COR
$1.1M
4,000 sh
$1.1M
Filed 05/28
Traded 05/28
- Lauren M. Tyler
BuyCencora
BuyCencora
COR
$148.6K
550 sh
$148.6K
Filed 06/24
Traded 06/22
- John Boozman
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$1K–$15K
Joint
$1K–$15K
Reported 07/13
Traded 06/04
- Kathryn E. Wengel
SellJohnson & Johnson
SellJohnson & Johnson
JNJ
$2.4M
10,000 sh
$2.4M
Filed 06/12
Traded 06/11
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$1.4M
10,900 sh
$1.4M
Filed 06/02
Traded 06/01
- Tommy Tuberville
Full salePfizer
Full salePfizer
PFE
$15K–$50K
Joint
$15K–$50K
Reported 07/16
Traded 06/08
- Brian S. Tyler
Sell10b5-1 planMcKesson
Sell10b5-1 planMcKesson
MCK
$6.6M
8,463 sh
$6.6M
Filed 06/18
Traded 06/17
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$404.9K
3,062 sh
$404.9K
Filed 06/02
Traded 06/01
- Andrew D. Dickinson
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$376.2K
3,000 sh
$376.2K
Filed 06/16
Traded 06/15
- Brian S. Tyler
Sell10b5-1 planMcKesson
Sell10b5-1 planMcKesson
MCK
$3.8M
4,929 sh
$3.8M
Filed 06/11
Traded 06/09
- Thomas Kean
Partial saleJohnson & Johnson
Partial saleJohnson & Johnson
JNJ
$1K–$15K
Self
$1K–$15K
Reported 07/15
Traded 06/29
- Thomas Kean
Partial saleJohnson & Johnson
Partial saleJohnson & Johnson
JNJ
$1K–$15K
Self
$1K–$15K
Reported 07/15
Traded 06/02
- Rick Larsen
BuyMcKesson
BuyMcKesson
MCK
$1K–$15K
Self
$1K–$15K
Reported 07/12
Traded 07/08
- Ilya Yuffa
Sell10b5-1 planELI Lilly
Sell10b5-1 planELI Lilly
LLY
$2.9M
2,500 sh
$2.9M
Filed 06/11
Traded 06/10
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$138K
1,038 sh
$138K
Filed 06/02
Traded 06/01
- Jennifer B. Damico
SellPfizer
SellPfizer
PFE
$51.4K
2,000 sh
$51.4K
Filed 06/10
Traded 06/09
- Dan Newhouse
Full saleUnitedhealth Group
Full saleUnitedhealth Group
UNH
$1K–$15K
Spouse
$1K–$15K
Reported 07/17
Traded 07/10
- Maria Salazar
Full saleUnitedhealth Group
Full saleUnitedhealth Group
UNH
$1K–$15K
Self
$1K–$15K
Reported 07/07
Traded 06/04
- Michele Lau
Sell10b5-1 planMcKesson
Sell10b5-1 planMcKesson
MCK
$2.7M
3,550 sh
$2.7M
Filed 05/27
Traded 05/26